Embecta Corp. (EMBC) income statement
EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3080% below fair value
$6.09−0.06 (-0.98%)
Close on Nov 18, 2026Market cap $345.06MP/E 4.1Yield 9.85%
Embecta Corp. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 59.0%
- Operating margin
- 21.9%
- Net margin
- 8.6%
- Return on equity, FY2025
- -13.7%
Financial strength
- Current ratio
- 1.68
- Debt to equity
- -2.37
- Debt to assets
- 115.0%
- Cash to current liabilities
- 51.1%
Valuation
- P/E ratio
- 4.1
- Price to sales
- 0.34
- Price to book
- –
- Dividend yield
- 9.85%
See a number that looks wrong?